Jim Simons’s CureVac CVAC Stock Holding History

Jim Simons’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-99,348	Closed	-$783K	–	4154
2022 Q3	$783K	Buy	+99,348	New	+$1.16M	﹤0.01%	2647

Other funds holding CVAC

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jim Simons's CVAC Position: Q4 2022 in Review

Jim Simons sold out of CureVac (CVAC) in Q4 2022, closing a stake of 99,348 shares — an estimated $783K sold.

Jim Simons first reported a position in CVAC in Q3 2022 and held it in 1 quarter. The position peaked at $783K in Q3 2022. 83 funds tracked by Wall St. Rank hold CVAC as of Q4 2022.

Jim Simons reported no remaining CureVac position as of Q4 2022 after selling out during the quarter.
Jim Simons sold 99,348 CureVac shares in Q4 2022, an estimated $783K.
Jim Simons first reported a position in CureVac in Q3 2022 and held it in 1 quarter.
Jim Simons's CureVac position peaked at $783K in Q3 2022.
83 funds tracked by Wall St. Rank held CureVac as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.